Table 2.
Correlation between histopathologic and laboratory parameters with severity of bullous pemphigoid.
| Variables | Objective BPDAI | Subjective BPDAI | Urticarial/eczematous lesion | Erosive/bullous lesions | Mucosal lesions |
|---|---|---|---|---|---|
| Anti-BP180 |
r = .82 p < .0001 |
r = .56 p = .002 |
r = .787 p < .0001 |
r = .65 p < .0001 |
r = .009 p = .96 |
| Anti-BP230 |
r = .64 p < .0001 |
r = .43 p = .025 |
r = .71 p < .0001 |
r = .428 p = .026 |
r = .06 p = .76 |
| Eosinophil count |
r = .36 p = .062 |
r = .35 p = .07 |
r = .368 p = .059 |
r = .28 p = .156 |
r = -.19 p = .31 |
| Eosinophil percent |
r = .378 p = .052 |
r = .41 p = .03 |
r = .38 p = .049 |
r = .29 p = .139 |
r = -.21 p = .28 |
| Dermal eosinophils |
r = .47 p = .012 |
r = .44 p = .022 |
r = .34 p = .23 |
r = .53 p = .004 |
r = .13 p = .49 |
| Tissue inflammation |
r = .57 p = .002 |
r = .44 p = .022 |
r = .55 p = .003 |
r = .44 p = .02 |
r = -.08 p = .97 |
BPDAI, bullous pemphigoid disease activity index.